From the Archives -  Expert Perspectives

In honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Board discusses factors in the risk and prevention of breast cancer. Ms. Shockney shares advice for minimizing one's risk of developing breast cancer and explains the genetic factors that can come into play in the development of this disease.

Breast Cancer Risk Factors and Prevention With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

In honor of Breast Cancer Awareness Month, Lillie Shockney RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Board, discusses the genetic factors that come into play in the development of breast cancer. In addition, she shares advice for which individuals should receive genetic testing and when, as well as strategies for counseling individuals who are undergoing genetic testing.

Breast Cancer Genetic Risk and Evaluation With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

In her latest Breast Cancer Awareness Month video, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses the importance of undergoing 3D mammography breast cancer screening, as well as the crucial role of breast imaging radiologists in this field.

Importance of 3D Mammogram Screening by Breast Imaging Radiologists With Lillie S. Shockney, RN

In this interview, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and medical advisory council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.

Breast Cancer Pathology and Setting the Stage for Treatment: Lillie Shockney, RN, HON-ONN-CG

For this podcast in honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses current standards and recent advances in breast cancer surgery, including lumpectomies, prophylactic mastectomies, and reconstructive procedures.

Understanding Breast Cancer Surgery and Reconstruction: Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating agents (HMA) for patients with myelodysplastic syndromes (MDS). In this interview, Dr. Zeidan further delves into his research and what it could mean for the future treatment landscape of MDS.

Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan

Oncology Data Advisor®